Table 2.
Association of KRT8 expression with clinicopathological features in PDAC patients from TCGA.
| Variables | Case (number, %) | KRT8 expression level (number, %) | P value | |
|---|---|---|---|---|
| High expression (N = 83) | Low expression (N = 84) | |||
| Age (years) | ≤55 (19.8) | 17 (51.5) | 16 (48.5) | 0.848 |
| >55 (80.2) | 66 (49.3) | 68 (50.7) | ||
| Histologic grade | G1+G2 (70.1) | 54 (46.2) | 63 (53.8) | 0.161 |
| G3+G4 (29.9) | 29 (58.0) | 21 (42.0) | ||
| N classification | N0 (28.1) | 22 (46.8) | 25 (53.2) | 0.640 |
| N1 (71.9) | 61 (50.8) | 59 (49.2) | ||
| T classification | T1+T2 (16.8) | 8 (28.6) | 20 (71.4) | 0.014 |
| T3+T4 (83.2) | 75 (54.0) | 64 (46.0) | ||
| Gender | Female (45.5) | 34 (44.7) | 42 (55.3) | 0.241 |
| Male (54.5) | 49 (53.8) | 42 (46.2) | ||
| Stage | Stage I+II (95.8) | 81 (50.6) | 79 (49.4) | 0.253 |
| Stage III+IV (4.2) | 2 (28.6) | 5 (71.4) | ||
Italicized value indicates P < 0.05.